Cybin and Clarmin Announce Closing of CDN$45 Million Oversubscribed Private Placement and Provide Update on RTO Pharmaceutical Investing
MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing Psychedelics Investing
Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange Psychedelics Investing
Numinus Appoints Multidisciplinary Global Leaders to its General Advisory Council Cannabis Investing News
Mydecine Innovations Group subsidiary NeuroPharm Engages FreeMind Group to Access Non-Dilutive Global Funding Opportunities Psychedelics Investing
Nutritional High Announces Approval of the Proposed Amendments to the 10% Senior Unsecured Convertible Debentures and Extension of the Term of the 12% Senior Secured Convertible Debentures Cannabis Investing News
Field Trip Adds Acclaimed Physician, Dr. Andrew Weil, to Medical Advisory Board Psychedelics Investing
